Loading clinical trials...
Loading clinical trials...
Chronic obstructive pulmonary disease (COPD) is number four of the leading causes of death in the USA and Europe. Moreover, among the top five causes of death, this disease is the only one with increa...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Paracelsus Medical University
NCT07665931 · Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hyperinflation
NCT07646587 · COPD (Chronic Obstructive Pulmonary Disease)
NCT05743582 · Chronic Obstructive Pulmonary Disease
NCT07190222 · Chronic Obstructive Pulmonary Disease
NCT07047092 · Chronic Obstructive Pulmonary Disease Exacerbation, Obstructive Sleep Apnea Exacerbation
Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University Salzburg
Salzburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions